3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Uterine Cervical Neoplasms
2
Sarcoma
2
Oropharyngeal Neoplasms
2
Lung Neoplasms
2
Hodgkin Disease
2
Cholangiocarcinoma
2
Carcinoma, Hepatocellular
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Rhabdoid Tumor
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Paraganglioma
1
Ovarian Neoplasms
1
Neoplasms
1
Multiple Myeloma
1
Mesothelioma
1
Melanoma
1
Lymphoma, Mantle-Cell
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leukemia, Plasma Cell
1
HIV Infections
1
Disease
1
Chordoma
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
pertuzumab
3
Trastuzumab
3
Docetaxel
2
tucatinib
1
atezolizumab
1
Paclitaxel
1
Neoadjuvant Therapy
1
Genetic Testing
1
Capecitabine
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
HER2-positive Breast Cancer
×
Fluorodeoxyglucose F18
×
30 days
×
Clear all
No trials found.